These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 23295156)
1. L-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-γ expression. Zambrano S; Blanca AJ; Ruiz-Armenta MV; Miguel-Carrasco JL; Arévalo M; Vázquez MJ; Mate A; Vázquez CM Biochem Pharmacol; 2013 Apr; 85(7):937-44. PubMed ID: 23295156 [TBL] [Abstract][Full Text] [Related]
2. L-carnitine attenuates the development of kidney fibrosis in hypertensive rats by upregulating PPAR-γ. Zambrano S; Blanca AJ; Ruiz-Armenta MV; Miguel-Carrasco JL; Arévalo M; Mate A; Vázquez CM Am J Hypertens; 2014 Mar; 27(3):460-70. PubMed ID: 24413708 [TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320 [TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan. Iwamoto M; Hirohata S; Ogawa H; Ohtsuki T; Shinohata R; Miyoshi T; Hatipoglu FO; Kusachi S; Yamamoto K; Ninomiya Y Hypertens Res; 2010 Dec; 33(12):1305-11. PubMed ID: 20944640 [TBL] [Abstract][Full Text] [Related]
5. The renoprotective effect of L-carnitine in hypertensive rats is mediated by modulation of oxidative stress-related gene expression. Zambrano S; Blanca AJ; Ruiz-Armenta MV; Miguel-Carrasco JL; Revilla E; Santa-María C; Mate A; Vázquez CM Eur J Nutr; 2013 Sep; 52(6):1649-59. PubMed ID: 23223967 [TBL] [Abstract][Full Text] [Related]
6. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats. Akashiba A; Ono H; Ono Y; Ishimitsu T; Matsuoka H J Cardiol; 2008 Dec; 52(3):239-46. PubMed ID: 19027602 [TBL] [Abstract][Full Text] [Related]
8. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats. Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083 [TBL] [Abstract][Full Text] [Related]
9. Exercise training attenuates age-dependent elevation of angiotensin II type 1 receptor and Nox2 signaling in the rat heart. Lee Y; Kwak HB; Hord J; Kim JH; Lawler JM Exp Gerontol; 2015 Oct; 70():163-73. PubMed ID: 26239262 [TBL] [Abstract][Full Text] [Related]
10. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts. Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328 [TBL] [Abstract][Full Text] [Related]
11. Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes. Lee TI; Kao YH; Chen YC; Pan NH; Lin YK; Chen YJ Clin Sci (Lond); 2011 Oct; 121(7):305-12. PubMed ID: 21501116 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory and fibrotic processes are involved in the cardiotoxic effect of sunitinib: Protective role of L-carnitine. Blanca AJ; Ruiz-Armenta MV; Zambrano S; Miguel-Carrasco JL; Arias JL; Arévalo M; Mate A; Aramburu O; Vázquez CM Toxicol Lett; 2016 Jan; 241():9-18. PubMed ID: 26581635 [TBL] [Abstract][Full Text] [Related]
13. A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats. Hermida N; López B; González A; Dotor J; Lasarte JJ; Sarobe P; Borrás-Cuesta F; Díez J Cardiovasc Res; 2009 Feb; 81(3):601-9. PubMed ID: 19019833 [TBL] [Abstract][Full Text] [Related]
14. Carthamus Tinctorius L. extract attenuates cardiac remodeling in L-NAME-induced hypertensive rats by inhibiting the NADPH oxidase-mediated TGF-β1 and MMP-9 pathway. Bunbupha S; Pakdeechote P; Maneesai P; Prachaney P; Boonprom P Ann Anat; 2019 Mar; 222():120-128. PubMed ID: 30590121 [TBL] [Abstract][Full Text] [Related]
15. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells. Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790 [TBL] [Abstract][Full Text] [Related]
16. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan]. Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501 [TBL] [Abstract][Full Text] [Related]
17. PPAR-γ is involved in the protective effect of 2,3,4',5-tetrahydroxystilbene-2-O-beta-D-glucoside against cardiac fibrosis in pressure-overloaded rats. Peng Y; Zeng Y; Xu J; Huang XL; Zhang W; Xu XL Eur J Pharmacol; 2016 Nov; 791():105-114. PubMed ID: 27568841 [TBL] [Abstract][Full Text] [Related]
18. The role of inflammatory markers in the cardioprotective effect of L-carnitine in L-NAME-induced hypertension. Miguel-Carrasco JL; Mate A; Monserrat MT; Arias JL; Aramburu O; Vázquez CM Am J Hypertens; 2008 Nov; 21(11):1231-7. PubMed ID: 18787523 [TBL] [Abstract][Full Text] [Related]
19. [The stereology of the myocardium in rats hypertensive due to the use of an inhibitor of nitric oxide synthesis]. Pereira LM; Mandarim-de-Lacerda CA Rev Port Cardiol; 1997 Oct; 16(10):753-9, 743. PubMed ID: 9479938 [TBL] [Abstract][Full Text] [Related]
20. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine. Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]